The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.
The Trump administration announced tariffs of 10% to 12.5% on 60 trading partners, including the European Union, over alleged failures to enforce forced labor import bans. The duties will take effect at the same moment temporary 10% global tariffs expire, although a senior administration official disputed describing them as a direct replacement.
